SPCs for combination products: a combination of requirements?
On 25 July 2018, the Court of Justice of the European Union handed down a judgment in Teva v Gilead concerning Supplementary Protection Certificates and, in particular, what determines whether a product comprising a combination of active ingredients is "protected by a basic patent".